{"id":"050036210658-03","name":"Swedish Orphan Biovitrum","registrationDate":"2013-02-21T07:54:44.160+01:00","category":2,"subCategory":3,"legal":"Public company","web":"http://www.sobi.com","country":"Sweden","headAddress":"Tomtebodev√§gen, 23A","headCity":"Stockholm","headPostCode":"SE-11276","headPhone":"(46)86 97 20 00","boss":"Guido Oelkers","bossTitle":"Mr","bossPosition":"Chief Executive Officer","membersCount":2,"membersFTE":"0.5","membership":"At European level, Sobi is an active participant in the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) and a member company of the European Association for BioIndustries (EuropaBio).  At national level, Sobi is a member of several local representative bodies.  These are listed on www.sobi.com or are available upon request.","memberOrga":"","goal":"Sobi is an international specialty healthcare company dedicated to rare diseases.  Our mission is to develop and deliver innovative therapies and services to improve the lives of patients.  The product portfolio is primarily focused on inflammation and rare genetic diseases.  Sobi also markets a portfolio of specialty and rare disease products for partner companies.  Sobi is a pioneer in biotechnology with world-class capabilities in protein biochemistry and biologics manufacturing.","acronym":"Sobi","interests":"Enterprise, Public Health, Research and Technology","euInitiatives":"Orphan Medicinal Products, rare disease policies, pricing &amp; reimbursement, Health Technology Assessment","lastUp":"2017-05-23T00:07:02.177+01:00","customers":"","costAbsolu":"","costRange":"25000-49999","turnoverAbsolu":0,"turnoverRange":""}